Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Duarte-García

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|October 15, 2019
Older Drugs With Limited Trial Evidence: Are They Worth the Expense?Ali Duarte-García, Eric L Matteson, Nilay D Shah
Annals of Internal Medicine|May 7, 2019
Older Drugs With Limited Trial Evidence: Are They Worth the Expense? The Case of Repository Corticotropin Marketed as H.P. Acthar GelAli Duarte-García, Eric L Matteson, Nilay D Shah
Annals of the Rheumatic Diseases|December 12, 2018
Disease progression of Takayasu arteritis in two patients treated with tocilizumabCatalina Sanchez-Alvarez, Matthew Koster, Ali Duarte-García, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2019
ReplyAli Duarte-García, Cynthia S Crowson, Kenneth J Warrington, et al.
Annals of the Rheumatic Diseases|August 10, 2020
Response to: 'Correspondence on '<i>Festina lente</i>: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef <i>et al</i>' by Lo <i>et al</i>Ali Duarte-García, Elizabeth R Graef, Jean W Liew, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 9, 2019
The Epidemiology of Antiphospholipid Syndrome: A Population-Based StudyAli Duarte-García, Michael M Pham, Cynthia S Crowson, et al.
Annals of the Rheumatic Diseases|February 22, 2022
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot studyMatthew J Koster, Cynthia S Crowson, Rachel E Giblon, et al.
Seminars in Thrombosis and Hemostasis|January 20, 2026
Patterns of Antiphospholipid Antibody Testing and Positivity in a Real-World Laboratory over Two Decades: The Role of IgMMaria Lizarazo Jimenez, Damon E Houghton, Ali Duarte-García, et al.
The Lancet. Rheumatology|February 14, 2022
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyMichael Putman, Kevin Kennedy, Emily Sirotich, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|October 15, 2019
Older Drugs With Limited Trial Evidence: Are They Worth the Expense?Ali Duarte-García, Eric L Matteson, Nilay D Shah
Annals of Internal Medicine|May 7, 2019
Older Drugs With Limited Trial Evidence: Are They Worth the Expense? The Case of Repository Corticotropin Marketed as H.P. Acthar GelAli Duarte-García, Eric L Matteson, Nilay D Shah
Annals of the Rheumatic Diseases|December 12, 2018
Disease progression of Takayasu arteritis in two patients treated with tocilizumabCatalina Sanchez-Alvarez, Matthew Koster, Ali Duarte-García, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2019
ReplyAli Duarte-García, Cynthia S Crowson, Kenneth J Warrington, et al.
Annals of the Rheumatic Diseases|August 10, 2020
Response to: 'Correspondence on '<i>Festina lente</i>: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef <i>et al</i>' by Lo <i>et al</i>Ali Duarte-García, Elizabeth R Graef, Jean W Liew, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 9, 2019
The Epidemiology of Antiphospholipid Syndrome: A Population-Based StudyAli Duarte-García, Michael M Pham, Cynthia S Crowson, et al.
Annals of the Rheumatic Diseases|February 22, 2022
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot studyMatthew J Koster, Cynthia S Crowson, Rachel E Giblon, et al.
Seminars in Thrombosis and Hemostasis|January 20, 2026
Patterns of Antiphospholipid Antibody Testing and Positivity in a Real-World Laboratory over Two Decades: The Role of IgMMaria Lizarazo Jimenez, Damon E Houghton, Ali Duarte-García, et al.
The Lancet. Rheumatology|February 14, 2022
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyMichael Putman, Kevin Kennedy, Emily Sirotich, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
Pageof 2